1. Synthesis and biological evaluation of N-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)benzenesulfonamide derivatives as new BET bromodomain inhibitors for anti-hematologic malignancies activities
    Li Liu et al, 2017, Mol Divers CrossRef
  2. TRAF6 as an NF-κB-modulating therapeutic target in cardiovascular diseases: at the heart of it all
    Muhammad Abdullah et al, 2017, Translational Research CrossRef
  3. The BET/BRD inhibitor JQ1 attenuates diabetes-induced cognitive impairment in rats by targeting Nox4-Nrf2 redox imbalance
    Ershun Liang et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  4. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure
    Qiming Duan et al, 2017, Sci. Transl. Med. CrossRef
  5. MicroRNA-29a mitigation of toll-like receptor 2 and 4 signaling and alleviation of obstructive jaundice-induced fibrosis in mice
    Yen-Cheng Lin et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  6. Inhibition of BRD4 attenuates cardiomyocyte apoptosis via NF-κB pathway in a rat model of myocardial infarction
    Yiping Sun et al, 2018, Cardiovasc Ther CrossRef
  7. The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart
    Kate Herum et al, 2017, JCM CrossRef
  8. Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats
    Keiya Takahashi et al, 2018, NeuroReport CrossRef
  9. null
    Asish K. Ghosh et al, 2018 CrossRef
  10. Genome-Wide Dynamics of Nascent Noncoding RNA Transcription in Porcine Heart After Myocardial Infarction
    Minna U. Kaikkonen et al, 2017, Circ Cardiovasc Genet CrossRef
  11. BRD4 expression in patients with essential hypertension and its effect on blood pressure in spontaneously hypertensive rats
    Yan-Min Yang et al, 2018, Journal of the American Society of Hypertension CrossRef
  12. The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats
    Jérôme Piquereau et al, 2019, IJMS CrossRef
  13. Drugging transcription in heart failure
    Arun Padmanabhan et al, 2019, J Physiol CrossRef
  14. Spotlight on epigenetic reprogramming in cardiac regeneration
    Carolina Soler-Botija et al, 2019, Seminars in Cell & Developmental Biology CrossRef
  15. I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targetting BRD4 in multiple myeloma
    Ning-Hong Guo et al, 2019, Biosci. Rep. CrossRef
  16. RVX 208: A novel BET protein inhibitor, role as an inducer of apo A-I/HDL and beyond
    Gopal C. Ghosh et al, 2017, Cardiovasc Ther CrossRef
  17. A concise review of recent advances in anti-heart failure targets and its small molecules inhibitors in recent years.
    Xingxing Li et al, 2020, Eur J Med Chem CrossRef
  18. Clinical Prescription-Protein-Small Molecule-Disease Strategy (CPSD), A New Strategy for Chinese Medicine Development: A Case Study in Cardiovascular Diseases
    Yong-Zhi Guo et al, 2020, Front. Pharmacol. CrossRef
  19. How progressive cancer endangers the heart: an intriguing and underestimated problem
    Simonetta Ausoni et al, 2020, Cancer Metastasis Rev CrossRef
  20. The therapeutic potential of BRD4 in cardiovascular disease
    Shigang Lin et al, 2020, Hypertens Res CrossRef
  21. Inhibition of myeloid differentiation protein 2 attenuates renal ischemia/reperfusion-induced oxidative stress and inflammation via suppressing TLR4/TRAF6/NF-kB pathway
    Xiaojun Hu et al, 2020, Life Sciences CrossRef
  22. Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses
    Niklas Remke et al, 2020, Cancer Immunol Immunother CrossRef
  23. Function of BRD4 in the pathogenesis of high glucose‑induced cardiac hypertrophy
    Qian Wang et al, 2018, Mol Med Report CrossRef
  24. MicroRNA‑146b induces the PI3K/Akt/NF‑κB signaling pathway to reduce vascular�inflammation and apoptosis in myocardial infarction by targeting PTEN
    Li Zhao et al, 2018, Exp Ther Med CrossRef
  25. Fluvastatin inhibits cardiomyocyte apoptosis after myocardial infarction through Toll pathway
    Lili Jia et al, 2018, Exp Ther Med CrossRef
  26. Isoquercetin ameliorates myocardial infarction through anti-inflammation and anti-apoptosis factor and regulating TLR4-NF-κB signal pathway
    Chengtai Ma et al, 2018, Mol Med Report CrossRef
  27. Astragaloside protects myocardial cells from apoptosis through suppression of the TLR4/NF-κB signaling pathway
    Yang Zhao et al, 2017, Exp Ther Med CrossRef
  28. Bromodomain‐containing protein 4 and its role in cardiovascular diseases
    Liang Li et al, 2020, J Cell Physiol CrossRef
  29. The BET family in immunity and disease
    Nian Wang et al, 2021, Sig Transduct Target Ther CrossRef
  30. null
    Emma Louise Robinson, 2021 CrossRef
  31. MicroRNA-375-3p in endothelial progenitor cells-derived extracellular vesicles relieves myocardial injury in septic rats via BRD4-mediated PI3K/AKT signaling pathway
    Xiaoyang Hong et al, 2021, International Immunopharmacology CrossRef
  32. Relevance of BET Family Proteins in SARS-CoV-2 Infection
    Nieves Lara-Ureña et al, 2021, Biomolecules CrossRef
  33. Dehydrocorydaline Protects Against Sepsis-Induced Myocardial Injury Through Modulating the TRAF6/NF-κB Pathway
    Yadong Li et al, 2021, Front. Pharmacol. CrossRef
  34. Melatonin Exerts Cardioprotective Effects by Inhibiting NLRP3 Inflammasome-Induced Pyroptosis in Mice following Myocardial Infarction
    Lianghe Wen et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  35. Cardioprotective effects of Amentoflavone by suppression of apoptosis and inflammation on an in vitro and vivo model of myocardial ischemia-reperfusion injury.
    Wei-Wei Li et al, 2021, Int Immunopharmacol CrossRef
  36. Retracted : IRAK3 gene silencing prevents cardiac rupture and ventricular remodeling through negative regulation of the NF‐κB signaling pathway in a mouse model of acute myocardial infarction
    Zhen‐Wei Ge et al, 2019, Journal Cellular Physiology CrossRef
  37. A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles
    Hafiz Akbar Ali et al, 2022, Front. Pharmacol. CrossRef
  38. Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy
    Li Fu et al, 2022, Pharmacology Res & Perspec CrossRef
  39. Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors
    Sumra Komal et al, 2022, Immunol Res CrossRef
  40. BRD4 inhibition by JQ1 protects against LPS-induced cardiac dysfunction by inhibiting activation of NLRP3 inflammasomes
    Wenjun Li et al, 2022, Mol Biol Rep CrossRef
  41. Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development
    Timothy A McKinsey et al, 2022 CrossRef
  42. Co-administration of JQ1, a bromodomain-containing protein 4 inhibitor, enhances the antitumor effect of combretastatin A4, a microtubule inhibitor, while attenuating its cardiotoxicity
    Haruka Orihara et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  43. BRD4 Inhibition by JQ1 Protects Against LPS-Induced Cardiac Dysfunction by Inhibiting SIRT1-Dependent Activation of NLRP3 Inflammasomes
    Wenjun Li et al, 2022, SSRN Journal CrossRef
  44. Anti‐tumor and cardiotoxic effects of microtubule polymerization inhibitors: The mechanisms and management strategies
    Ryota Tochinai et al, 2023, J of Applied Toxicology CrossRef
  45. Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8
    Tingting Wu et al, 2024, European Journal of Medicinal Chemistry CrossRef
  46. BRD4: an effective target for organ fibrosis
    Qun Wei et al, 2024, Biomark Res CrossRef
  47. BRD4 Inhibition Protects Against Myocardial Ischemia/Reperfusion Injury by Suppressing Inflammation and Oxidative Stress Through the PI3K/AKT Signaling Pathway.
    Hongwei Wei et al, 2021, J Cardiovasc Pharmacol CrossRef
  48. Exploring the Role of Licorice and Its Derivatives in Cell Signaling Pathway NF‐κB and MAPK
    Ieaman Fatima et al, 2024, Journal of Nutrition and Metabolism CrossRef